Promising clinical data surrounding the medication Retatrutide , specifically the 120mg formulation ZPHC ZPHC, reveal a significant benefit on weight loss and linked chronic illnesses . Researchers believe that this innovative acting , targeting both GLP-1 and GIP pathways , may represent a majo